À Propos de l'Entreprise
- Raison sociale: Sichuan Chenghua Bio-technology Co., Ltd
- Pays d'enregistrement: China
- Adresse: 733 Furong Avenue Section 2, Chengdu, • Sichuan
- Nombre d'employés: 25 - 49
Description:
Sichuan Chenghua Bio-Technology Co., Ltd. is a high-tech corporation engaged in drug declaration and manufacture of pharmaceuticals and intermediates, earning a good reputation at home and abroad through advanced technology, standardized management and a well-established service system. The company mainly produces UDCA, CDCA, Obeticholic Acid and their intermediates, Isavuconazonium Sulfate and intermediates, Posaconazole and intermediates, Omadacycline and intermediates, and other cholic acid products.
Activités Commerciales
Ingrédients Biologiques & de Fermentation
Fabricant
Principes Actifs Pharmaceutiques (API)
Fabricant de Principes Actifs (API)
Produits Chimiques Pharmaceutiques
FabricantFournisseur de Matières Premières
Marchés de Vente
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Northern America: Bermuda, Canada, Greenland, Saint Pierre and Miquelon, United States
Produits/Services Clés
- Principes Actifs Pharmaceutiques (API): Active Pharmaceutical Ingredients
- Produits Chimiques Pharmaceutiques: (2S,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)butanenitrile, Pharmaceutical Intermediates, Tauroursodeoxycholic acid, Chenodeoxycholic Acid ( CDCA), Posaconazole intermediate （POA）, Isavuconazonium sulfate, Obeticholic Acid Intermediate A, UDCA（ursodeoxycholic acid）, Omadacycline and intermediates
Nos Produits & Services
Certifications
Proofs
CPHI & PMEC China 2026
06/2026 – 06/2026
CPHI & PMEC China 2026
Évaluations
(0)
(0)
(0)
(0)
(0)
Commentaires
Filtres :
Trier par :
Aucun commentaire disponible.
Laissez votre note & commentaire